Wire · regulatory
China continues to strengthen regulation of Artificial Intelligence (AI) in the Life Sciences sectors
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 30 August 2026 · Fusion42 review
China is significantly expanding AI regulation in life sciences by enforcing multi-dimensional compliance across data provenance, algorithm governance, and cross-border data rules, with several regulatory documents issued since 2025 shaping mandatory ethical reviews and lifecycle oversight of AI in pharmaceuticals and healthcare.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
AI companies and healthtech providers must revisit their data and AI governance frameworks immediately to meet China's expanding legal requirements or risk losing market access. Rapidly entangle your contracts and data flows with new ethics and regulatory filings to stay compliant and operational.
◆ Coverage
1 source · 6 Aug 2026
◆ Related on Wire
◆ Topics